Author
The Petrie Flom Center recently welcomed Dov Fox, Professor of Law and the Director of the Center for Health Law Policy and Bioethics at the University of San Diego School of Law, to discuss his new book.
Following the passage of the Inflation Reduction Act’s (IRA) provision granting Medicare the authority to negotiate drug prices, pharmaceutical companies and allied organizations have brought a dozen lawsuits challenging the legality of the negotiation program.
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee…
Health policy experts, patient advocates, and the news media have understandably focused on the One Big Beautiful Bill’s threat to Medicaid. The budget reconciliation law, passed with slim GOP majorities and exclusive Democratic opposition in July, included numerous reforms to…
